Anti-Bacterial Agents

"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Substances that inhibit the growth or reproduction of BACTERIA.

Descriptor ID	D000900
MeSH Number(s)	D27.505.954.122.085
Concept/Terms	Anti-Bacterial Agents Anti-Bacterial Agents Agents, Anti-Bacterial Anti Bacterial Agents Antibacterial Agents Agents, Antibacterial Anti-Bacterial Compounds Anti Bacterial Compounds Compounds, Anti-Bacterial Bacteriocidal Agents Bacteriocidal Agents Agents, Bacteriocidal Bacteriocides Anti-Mycobacterial Agents Anti-Mycobacterial Agents Agents, Anti-Mycobacterial Anti Mycobacterial Agents Antimycobacterial Agents Agents, Antimycobacterial Antibiotics Antibiotics Antibiotic

Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Anti-Bacterial Agents [D27.505.954.122.085]

Below are MeSH descriptors whose meaning is related to "Anti-Bacterial Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.

Bar chart showing 808 publications over 28 distinct years, with a maximum of 53 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1995	0	1	1
1996	0	3	3
1997	0	2	2
2000	1	2	3
2001	0	2	2
2002	8	5	13
2003	23	10	33
2004	8	9	17
2005	16	11	27
2006	23	6	29
2007	35	13	48
2008	30	18	48
2009	18	17	35
2010	25	18	43
2011	18	16	34
2012	17	17	34
2013	23	14	37
2014	26	11	37
2015	32	14	46
2016	22	19	41
2017	25	21	46
2018	31	22	53
2019	34	16	50
2020	22	27	49
2021	14	25	39
2022	5	23	28
2023	2	7	9

Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.

Bozzo A, Yeung CM, Van De Sande M, Ghert M, Healey JH. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data. J Bone Joint Surg Am. 2023 07 19; 105(Suppl 1):65-72.

View in: PubMed
Zhao N, Curry D, Evans RE, Isguven S, Freeman T, Eisenbrey JR, Forsberg F, Gilbertie JM, Boorman S, Hilliard R, Dastgheyb SS, Machado P, Stanczak M, Harwood M, Chen AF, Parvizi J, Shapiro IM, Hickok NJ, Schaer TP. Microbubble cavitation restores Staphylococcus aureus antibiotic susceptibility in vitro and in a septic arthritis model. Commun Biol. 2023 04 17; 6(1):425.

View in: PubMed
Gangwani MK, Aziz M, Aziz A, Priyanka F, Weissman S, Phan K, Dahiya DS, Ahmed Z, Sohail AH, Lee-Smith W, Kamal F, Javaid T, Nawras A, Hart B. Fresh Versus Frozen Versus Lyophilized Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection: A Systematic Review and Network Meta-analysis. J Clin Gastroenterol. 2023 03 01; 57(3):239-245.

View in: PubMed
Karlowsky JA, Lob SH, Siddiqui F, Akrich B, DeRyke CA, Young K, Motyl MR, Hawser SP, Sahm DF. In vitro activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa collected from patients with bloodstream, intra-abdominal and urinary tract infections in Western Europe: SMART 2018-2020. J Med Microbiol. 2023 Feb; 72(2).

View in: PubMed
Lob SH, Hawser SP, Siddiqui F, Alekseeva I, DeRyke CA, Young K, Motyl MR, Sahm DF. Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland-SMART 2017-2020. Eur J Clin Microbiol Infect Dis. 2023 Mar; 42(3):365-370.

View in: PubMed
Kullar R, Chisari E, Snyder J, Cooper C, Parvizi J, Sniffen J. Next-Generation Sequencing Supports Targeted Antibiotic Treatment for Culture Negative Orthopedic Infections. Clin Infect Dis. 2023 01 13; 76(2):359-364.

View in: PubMed
Luterbach CL, Chen L, Komarow L, Ostrowsky B, Kaye KS, Hanson B, Arias CA, Desai S, Gallagher JC, Novick E, Pagkalinawan S, Lautenbach E, Wortmann G, Kalayjian RC, Eilertson B, Farrell JJ, McCarty T, Hill C, Fowler VG, Kreiswirth BN, Bonomo RA, van Duin D. Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals. Clin Infect Dis. 2023 Jan 13; 76(2):229-237.

View in: PubMed
Humphries RM, Janssen H, Hey-Hadavi JH, Hackel M, Sahm D. Multidrug-resistant Gram-negative bacilli recovered from respiratory and blood specimens from adults: the ATLAS surveillance program in European hospitals, 2018-2020. Int J Antimicrob Agents. 2023 Feb; 61(2):106724.

View in: PubMed
Karlowsky JA, Hackel MA, Stone GG, Sahm DF. In Vitro Activity of Ceftibuten-Avibactam against ?-Lactamase-Positive Enterobacterales from the ATLAS Global Surveillance Program. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0134622.

View in: PubMed
Villars J, Gardner CA, Zhan T, Binder AF. Delay in Time to Antibiotics for De Novo Inpatient Neutropenic Fever May Not Impact Overall Survival for Patients With a Cancer Diagnosis. Am J Med Qual. 2023 Jan-Feb 01; 38(1):9-16.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement